Divi’s Laboratories Q4 profit rises 13%, beating estimates; margin slips
The board of the Hyderabad-based pharmaceutical company also recommended a final dividend of ₹30 per share for FY26. By CNBCTV18May 23, 2026, 2:35:11 PM IST (Published) 1 Min Read Divi’s Laboratories reported a 13.4% year-on-year rise in net profit for the January-March quarter of FY26 at ₹751 crore, ahead of the CNBC-TV18 poll estimate of…
